- Home
- PRPO vs BCHT Comparison
PRPO vs BCHT Comparison
Compare PRPO & BCHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRPO | BCHT |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Industrial Machinery/Components |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.0M | 36.6M |
| IPO Year | 2000 | 2016 |
Fundamental Metrics
Financial Performance| Metric | PRPO | BCHT |
|---|---|---|
| Price | $23.21 | $1.46 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 84.8K | ★ 119.7K |
| Earning Date | 11-13-2026 | 11-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 92.15 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $24,049,000.00 | $17,626,366.00 |
| Revenue This Year | $233.72 | N/A |
| Revenue Next Year | $22.61 | $73.49 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 29.77 | 1.26 |
| 52 Week Low | $16.40 | $1.14 |
| 52 Week High | $33.63 | $2.48 |
Technical Indicators
Market Signals| Indicator | PRPO | BCHT |
|---|---|---|
| Relative Strength Index (RSI) | 40.20 | 44.77 |
| Support Level | $22.09 | $1.20 |
| Resistance Level | $24.95 | $1.54 |
| Average True Range (ATR) | 1.18 | 0.12 |
| MACD | -0.11 | -0.02 |
| Stochastic Oscillator | 18.10 | 8.11 |
Price Performance
Historical ComparisonAbout PRPO Precipio Inc.
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.
About BCHT Birchtech Corp. Common Stock
Birchtech Corp is a provider of specialty activated carbon technologies, delivering solutions for air and water purification. It provides patented and proprietary Sorbent Enhancement Additive (SEA) technologies for mercury emissions capture to the coal-fired utility sector, and is developing water purification technologies with a specialization on forever chemicals such as PFAS and PFOS. Geographically, the company derives all of its revenue from the United States.